National Hospital Organization Kyushu Cancer Center ( Site 2609)

Fukuoka 811-1395

0 studies enrolling now · 2 studies all time

What they study most

Advanced/Metastatic Gastroesophageal Adenocarcinoma, Gastric Neoplasms, Gastroesophageal Junction Adenocarcinoma

Studies at this site

• Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) Plus Chemotherapy in Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-7902-015/E7080-G000-321/LEAP-015) — Completed
• Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811) — Completed